Cooper Companies COO
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Cooper Companies (COO) Business Model and Operations Summary
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Key Insights
Cooper Companies (COO) Core Market Data and Business Metrics
Latest Closing Price
$81.23Market Cap
$16.12 BillionPrice-Earnings Ratio
-0.05Total Outstanding Shares
199.16 Million SharesTotal Employees
15,000Dividend
$0.03 Per Share BiannuallyIPO Date
December 6, 1983SIC Description
Ophthalmic GoodsPrimary Exchange
NASDAQHeadquarters
6101 Bollinger Canyon Road, San Ramon, CA, 94583
Historical Stock Splits
If you bought 1 share of COO before February 20, 2024, you'd have 4 shares today.
| Execution Date | Split Amount |
|---|---|
| February 20, 2024 | 4-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 2,913,532 Shares | 1.35 | 3/14/2025 | 3,945,861 Shares |
| 1,958,355 Shares | 1.57 | 2/28/2025 | 3,081,190 Shares |
| 1,113,951 Shares | 2.7 | 2/14/2025 | 3,002,945 Shares |
| 1,391,856 Shares | 2.06 | 1/31/2025 | 2,868,821 Shares |
| 1,387,632 Shares | 1.99 | 1/15/2025 | 2,762,833 Shares |
| 1,298,411 Shares | 2.11 | 12/31/2024 | 2,734,250 Shares |
Income Statement
November 1, 2024 to February 1, 2025
| Metric | Value |
|---|---|
| Net Income/Loss Available To Common Stockholders, Basic | $-38.17 Million |
| Diluted Earnings Per Share | $-800 |
| Income/Loss From Continuing Operations After Tax | $-38.17 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Net Income/Loss Attributable To Parent | $-38.17 Million |
| Operating Income/Loss | $-25.85 Million |
Comprehensive Income
November 1, 2024 to February 1, 2025
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $-38.17 Million |
| Other Comprehensive Income/Loss | $0 |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss Attributable To Parent | $-38.17 Million |
Balance Sheet
November 1, 2024 to February 1, 2025
| Metric | Value |
|---|---|
| Assets | $2.01 Billion |
| Other Non-current Assets | $981.56 Million |
| Temporary Equity Attributable To Parent | $3.28 Million |
| Noncurrent Liabilities | $1.14 Billion |
| Current Assets | $734.82 Million |
| Accounts Payable | $271.52 Million |
Historical Dividends
Current dividend: $0.03 Per Share Biannually
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jul 12, 2023 | Aug 11, 2023 | Jul 27, 2023 | $0.03 | Biannually |
| Dec 14, 2022 | Feb 10, 2023 | Jan 23, 2023 | $0.03 | Biannually |
| Jul 13, 2022 | Aug 11, 2022 | Jul 27, 2022 | $0.03 | Biannually |
| Dec 8, 2021 | Feb 9, 2022 | Jan 21, 2022 | $0.03 | Biannually |
| Jul 14, 2021 | Aug 11, 2021 | Jul 27, 2021 | $0.03 | Biannually |
| Jan 7, 2021 | Feb 9, 2021 | Jan 22, 2021 | $0.03 | Biannually |